Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Factors Associated with HIV Discussion and Condom Use with Sexual Partners in an Underserved Community in South Africa.

Conserve DF, Middelkoop K, King G, Bekker LG.

J Health Care Poor Underserved. 2016 Feb;27(1):131-144.

2.

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.

PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul.

3.

Protecting Our Front-liners: Occupational Tuberculosis Prevention Through Infection Control Strategies.

Verkuijl S, Middelkoop K.

Clin Infect Dis. 2016 May 15;62 Suppl 3:S231-7. doi: 10.1093/cid/civ1184.

PMID:
27118852
4.

Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals.

Hoehn KB, Gall A, Bashford-Rogers R, Fidler SJ, Kaye S, Weber JN, McClure MO; SPARTAC Trial Investigators., Kellam P, Pybus OG.

Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676). pii: 20140241. doi: 10.1098/rstb.2014.0241.

5.

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.

Hamlyn E, Stöhr W, Cooper DA, Fisher M, Tambussi G, Schechter M, Miro JM, Vanobberghen F, Babiker A, Weber J, Mcclure M, Porter K, Fidler S; SPARTAC Investigators..

AIDS. 2015 Jul 17;29(11):1355-61. doi: 10.1097/QAD.0000000000000675.

PMID:
25870986
6.

Shared locations of TB cases: places of acquisition or transmission of infection?

Hermans S, Middelkoop K, Wood R.

Trop Med Int Health. 2015 Jul;20(7):965. doi: 10.1111/tmi.12493. Epub 2015 Mar 17. No abstract available.

7.

Structured observations reveal slow HIV-1 CTL escape.

Roberts HE, Hurst J, Robinson N, Brown H, Flanagan P, Vass L, Fidler S, Weber J, Babiker A, Phillips RE, McLean AR, Frater J; SPARTAC trial investigators..

PLoS Genet. 2015 Feb 2;11(2):e1004914. doi: 10.1371/journal.pgen.1004914. eCollection 2015 Feb.

8.

Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission.

Kamali A, Price MA, Lakhi S, Karita E, Inambao M, Sanders EJ, Anzala O, Latka MH, Bekker LG, Kaleebu P, Asiki G, Ssetaala A, Ruzagira E, Allen S, Farmer P, Hunter E, Mutua G, Makkan H, Tichacek A, Brill IK, Fast P, Stevens G, Chetty P, Amornkul PN, Gilmour J; IAVI Africa HIV Prevention Partnership..

PLoS One. 2015 Jan 20;10(1):e0116100. doi: 10.1371/journal.pone.0116100. eCollection 2015.

9.

Reply to Yates et al.

Middelkoop K, Mathema B, Whitelaw A, Bekker LG, Wood R.

J Infect Dis. 2015 May 1;211(9):1510-1. doi: 10.1093/infdis/jiu629. Epub 2014 Nov 11. No abstract available.

10.

HIV-1 DNA predicts disease progression and post-treatment virological control.

Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, Kinloch S, Cooper D, Schechter M, Tambussi G, Fidler S, Carrington M, Babiker A, Weber J, Koelsch KK, Kelleher AD, Phillips RE, Frater J; SPARTACTrial Investigators..

Elife. 2014 Sep 12;3:e03821. doi: 10.7554/eLife.03821.

11.

Transmission of tuberculosis in a South African community with a high prevalence of HIV infection.

Middelkoop K, Mathema B, Myer L, Shashkina E, Whitelaw A, Kaplan G, Kreiswirth B, Wood R, Bekker LG.

J Infect Dis. 2015 Jan 1;211(1):53-61. doi: 10.1093/infdis/jiu403. Epub 2014 Jul 22.

12.

Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).

Kaplan R, Caldwell J, Middelkoop K, Bekker LG, Wood R.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):487-94. doi: 10.1097/QAI.0000000000000201.

13.

Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African township.

Middelkoop K, Bekker LG, Morrow C, Lee N, Wood R.

BMC Infect Dis. 2014 Apr 23;14:221. doi: 10.1186/1471-2334-14-221.

14.

Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community.

Middelkoop K, Bekker LG, Mathema B, Myer L, Shashkina E, Whitelaw A, Kurepina N, Kaplan G, Kreiswirth B, Wood R.

Int J Epidemiol. 2014 Aug;43(4):1114-22. doi: 10.1093/ije/dyu044. Epub 2014 Mar 7.

15.

Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa.

Middelkoop K, Rademeyer C, Brown BB, Cashmore TJ, Marais JC, Scheibe AP, Bandawe GP, Myer L, Fuchs JD, Williamson C, Bekker LG.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):473-80. doi: 10.1097/QAI.0000000000000067.

PMID:
24583617
16.

HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression.

Frater J, Ewings F, Hurst J, Brown H, Robinson N, Fidler S, Babiker A, Weber J, Porter K, Phillips RE; SPARTAC Trial Investigators..

AIDS. 2014 Mar 13;28(5):699-708. doi: 10.1097/QAD.0000000000000130.

PMID:
24549145
17.

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.

Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K; SPARTAC Trial Investigators..

AIDS. 2014 Mar 27;28(6):869-74. doi: 10.1097/QAD.0000000000000155.

PMID:
24300544
18.

Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters.

Gall A, Kaye S, Hué S, Bonsall D, Rance R, Baillie GJ, Fidler SJ, Weber JN, McClure MO, Kellam P; SPARTAC Trial Investigators..

Retrovirology. 2013 Jan 18;10:8. doi: 10.1186/1742-4690-10-8.

19.

Short-course antiretroviral therapy in primary HIV infection.

SPARTAC Trial Investigators., Fidler S, Porter K, Ewings F, Frater J, Ramjee G, Cooper D, Rees H, Fisher M, Schechter M, Kaleebu P, Tambussi G, Kinloch S, Miro JM, Kelleher A, McClure M, Kaye S, Gabriel M, Phillips R, Weber J, Babiker A.

N Engl J Med. 2013 Jan 17;368(3):207-17. doi: 10.1056/NEJMoa1110039.

20.

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.

Yager N, Robinson N, Brown H, Flanagan P, Frater J, Fidler S, Weber J, Phillips R; SPARTAC Trial Investigators..

AIDS. 2013 Jan 28;27(3):313-23. doi: 10.1097/QAD.0b013e32835b8cf5.

PMID:
23095315

Supplemental Content

Loading ...
Support Center